99 related articles for article (PubMed ID: 19954169)
1. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
Mondal S; Sarkar M
J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
[TBL] [Abstract][Full Text] [Related]
2. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
3. Membrane fusion: a new function of non steroidal anti-inflammatory drugs.
Chakraborty H; Mondal S; Sarkar M
Biophys Chem; 2008 Sep; 137(1):28-34. PubMed ID: 18617319
[TBL] [Abstract][Full Text] [Related]
4. Effect of increase in orientational order of lipid chains and head group spacing on non steroidal anti-inflammatory drug induced membrane fusion.
Roy SM; Bansode AS; Sarkar M
Langmuir; 2010 Dec; 26(24):18967-75. PubMed ID: 21114267
[TBL] [Abstract][Full Text] [Related]
5. Small Mismatches in Fatty Acyl Tail Lengths Can Effect Non Steroidal Anti-Inflammatory Drug Induced Membrane Fusion.
Majumdar A; Sarkar M
J Phys Chem B; 2016 Jun; 120(21):4791-802. PubMed ID: 27153337
[TBL] [Abstract][Full Text] [Related]
6. Modulation of non steroidal anti-inflammatory drug induced membrane fusion by copper coordination of these drugs: anchoring effect.
Majumdar A; Chakraborty S; Sarkar M
J Phys Chem B; 2014 Dec; 118(48):13785-99. PubMed ID: 25380501
[TBL] [Abstract][Full Text] [Related]
7. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
Chakraborty H; Roy S; Sarkar M
Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
[TBL] [Abstract][Full Text] [Related]
8. Interaction of piroxicam and meloxicam with DMPG/DMPC mixed vesicles: anomalous partitioning behavior.
Chakraborty H; Sarkar M
Biophys Chem; 2007 Feb; 125(2-3):306-13. PubMed ID: 17010502
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration.
Kundu S; Chakraborty H; Sarkar M; Datta A
Colloids Surf B Biointerfaces; 2009 Apr; 70(1):157-61. PubMed ID: 19157803
[TBL] [Abstract][Full Text] [Related]
10. Differential Effect of Oxicam Non-Steroidal Anti-Inflammatory Drugs on Membranes and Their Consequence on Membrane Fusion.
Majumdar A; Kundu D; Sarkar M
J Phys Chem B; 2015 Jul; 119(30):9627-39. PubMed ID: 26147344
[TBL] [Abstract][Full Text] [Related]
11. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
Banerjee R; Chakraborty H; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
[TBL] [Abstract][Full Text] [Related]
12. Effects of non-steroid anti-inflammatory drugs in membrane bilayers.
Kyrikou I; Hadjikakou SK; Kovala-Demertzi D; Viras K; Mavromoustakos T
Chem Phys Lipids; 2004 Dec; 132(2):157-69. PubMed ID: 15555602
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
Chakraborty H; Banerjee R; Sarkar M
Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
15. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
Roy S; Banerjee R; Sarkar M
J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
[TBL] [Abstract][Full Text] [Related]
16. The reactions of oxicam and sulfoanilide non steroidal anti-inflammatory drugs with hypochlorous acid: determination of the rate constants with an assay based on the competition with para-aminobenzoic acid chlorination and identification of some oxidation products.
Van Antwerpen P; Dubois J; Gelbcke M; Neve J
Free Radic Res; 2004 Mar; 38(3):251-8. PubMed ID: 15129733
[TBL] [Abstract][Full Text] [Related]
17. Forced and long-term degradation assays of tenoxicam, piroxicam and meloxicam in river water. Degradation products and adsorption to sediment.
Jiménez JJ; Muñoz BE; Sánchez MI; Pardo R
Chemosphere; 2018 Jan; 191():903-910. PubMed ID: 29145135
[TBL] [Abstract][Full Text] [Related]
18. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
Alladi S; Shastri NR
Arch Pharm Res; 2015; 38(5):801-12. PubMed ID: 24752862
[TBL] [Abstract][Full Text] [Related]
19. Scavenging of photogenerated ROS by Oxicams. Possible biological and environmental implications.
Ferrari GV; Natera J; Paulina Montaña M; Muñoz V; Gutiérrez EL; Massad W; Miskoski S; García NA
J Photochem Photobiol B; 2015 Dec; 153():233-9. PubMed ID: 26453988
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic probing of model lipid membranes: phospholipase A2 activity toward monolayers modified by oxicam NSAIDs.
Czapla K; Korchowiec B; Orlof M; Magnieto JR; Rogalska E
J Phys Chem B; 2011 Jul; 115(29):9290-8. PubMed ID: 21682312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
